<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Beentjes CHL</submitter><funding>British Heart Foundation</funding><funding>Medical Research Council</funding><funding>Wellbeing of Women</funding><funding>NIH</funding><funding>NIAMS NIH HHS</funding><funding>Wellcome Trust</funding><funding>Biotechnology and Biological Sciences Research Council</funding><funding>Engineering and Physical Sciences Research Council</funding><pagination>152-160</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7614536</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>190</volume><pubmed_abstract>Vitamin D deficiency is linked to adverse pregnancy outcomes such as pre-eclampsia (PET) but remains defined by serum measurement of 25-hydroxyvitamin D3 (25(OH)D3) alone. To identify broader changes in vitamin D metabolism during normal and PET pregnancies we developed a relatively simple but fully parametrised mathematical model of the vitamin D metabolic pathway. The data used for parametrisation were serum vitamin D metabolites analysed for a cross-sectional group of women (n = 88); including normal pregnant women at 1 st (NP1, n = 25) and 3rd trimester (NP3, n = 21) and pregnant women with PET (n = 22), as well as non-pregnant female controls (n = 20). To account for the effects various metabolites have upon each other, data were analysed using an ordinary differential equation model of the vitamin D reaction network. Information obtained from the model was then also applied to serum vitamin D metabolome data (n = 50) obtained from a 2nd trimester pregnancy cohort, of which 25 prospectively developed PET. Statistical analysis of the data alone showed no significant difference between NP3 and PET for serum 25(OH)D3 and 24,25(OH)&lt;sub>2&lt;/sub>D3 concentrations. Conversely, a statistical analysis informed by the reaction network model revealed that a better indicator of PET is the ratios of vitamin D metabolites in late pregnancy. Assessing the potential predicative value, no significant difference between NP3 and PET cases at 15 weeks gestation was found. Mathematical modelling offers a novel strategy for defining the impact of vitamin D metabolism on human health. This is particularly relevant within the context of pregnancy, where major changes in vitamin D metabolism occur across gestation, and dysregulated metabolism is evidenced in women with established PET.</pubmed_abstract><journal>The Journal of steroid biochemistry and molecular biology</journal><pubmed_title>Defining vitamin D status using multi-metabolite mathematical modelling: A pregnancy perspective.</pubmed_title><pmcid>PMC7614536</pmcid><funding_grant_id>EP/G037280/1</funding_grant_id><funding_grant_id>101222/Z/13/Z</funding_grant_id><funding_grant_id>BB/M025888/1</funding_grant_id><funding_grant_id>R01 AR063910</funding_grant_id><funding_grant_id>101222</funding_grant_id><funding_grant_id>BB/M021386/1</funding_grant_id><funding_grant_id>PG/16/20/32074</funding_grant_id><funding_grant_id>AR063910</funding_grant_id><funding_grant_id>EP/L001101/1</funding_grant_id><funding_grant_id>RTF401</funding_grant_id><funding_grant_id>1615996</funding_grant_id><pubmed_authors>Hewison M</pubmed_authors><pubmed_authors>Beentjes CHL</pubmed_authors><pubmed_authors>Taylor-King JP</pubmed_authors><pubmed_authors>Jabbari S</pubmed_authors><pubmed_authors>Mirams GR</pubmed_authors><pubmed_authors>Tamblyn JA</pubmed_authors><pubmed_authors>Dunster JL</pubmed_authors><pubmed_authors>Davis CN</pubmed_authors><pubmed_authors>Kilby MD</pubmed_authors><pubmed_authors>Bayani A</pubmed_authors><pubmed_authors>Jenkinson C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Defining vitamin D status using multi-metabolite mathematical modelling: A pregnancy perspective.</name><description>Vitamin D deficiency is linked to adverse pregnancy outcomes such as pre-eclampsia (PET) but remains defined by serum measurement of 25-hydroxyvitamin D3 (25(OH)D3) alone. To identify broader changes in vitamin D metabolism during normal and PET pregnancies we developed a relatively simple but fully parametrised mathematical model of the vitamin D metabolic pathway. The data used for parametrisation were serum vitamin D metabolites analysed for a cross-sectional group of women (n = 88); including normal pregnant women at 1 st (NP1, n = 25) and 3rd trimester (NP3, n = 21) and pregnant women with PET (n = 22), as well as non-pregnant female controls (n = 20). To account for the effects various metabolites have upon each other, data were analysed using an ordinary differential equation model of the vitamin D reaction network. Information obtained from the model was then also applied to serum vitamin D metabolome data (n = 50) obtained from a 2nd trimester pregnancy cohort, of which 25 prospectively developed PET. Statistical analysis of the data alone showed no significant difference between NP3 and PET for serum 25(OH)D3 and 24,25(OH)&lt;sub>2&lt;/sub>D3 concentrations. Conversely, a statistical analysis informed by the reaction network model revealed that a better indicator of PET is the ratios of vitamin D metabolites in late pregnancy. Assessing the potential predicative value, no significant difference between NP3 and PET cases at 15 weeks gestation was found. Mathematical modelling offers a novel strategy for defining the impact of vitamin D metabolism on human health. This is particularly relevant within the context of pregnancy, where major changes in vitamin D metabolism occur across gestation, and dysregulated metabolism is evidenced in women with established PET.</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Jun</publication><modification>2025-04-04T02:25:58.609Z</modification><creation>2025-02-19T01:23:39.034Z</creation></dates><accession>S-EPMC7614536</accession><cross_references><pubmed>30926429</pubmed><doi>10.1016/j.jsbmb.2019.03.024</doi></cross_references></HashMap>